Charles M. Baum - Jun 18, 2021 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role: President & CEO, Director
Signature: /s/ Vickie Reed, Attorney-in-Fact
Stock symbol: MRTX
Transactions as of: Jun 18, 2021
Transactions value $: -$6,278,633
Form type: 4
Date filed: 6/21/2021, 05:12 PM
Previous filing: Jun 9, 2021
Next filing: Dec 3, 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRTX	Common Stock	Options Exercise	$340K	+40K	+35.49%	$8.49^*	153K	Jun 18, 2021	Direct	F1
transaction	MRTX	Common Stock	Sale	-$790K	-4.82K	-3.15%	$164.07	148K	Jun 18, 2021	Direct	F1, F2
transaction	MRTX	Common Stock	Sale	-$2.2M	-13.3K	-9.02%	$164.90	135K	Jun 18, 2021	Direct	F1, F3
transaction	MRTX	Common Stock	Sale	-$3.46M	-20.8K	-15.47%	$166.07	114K	Jun 18, 2021	Direct	F1, F4
transaction	MRTX	Common Stock	Sale	-$171K	-1.02K	-0.9%	$166.73	113K	Jun 18, 2021	Direct	F1, F5

Showing 1 to 5 of 5 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRTX	Employee Stock Option (Right to Buy)	Options Exercise	$0	-40K	-45.87%	$0.00	47.2K	Jun 18, 2021	Common Stock	40K	$8.49	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2020.
F2	This transaction was executed in multiple trades at prices ranging from $163.45 to $164.41. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	This transaction was executed in multiple trades at prices ranging from $164.47 to $165.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4	This transaction was executed in multiple trades at prices ranging from $165.53 to $166.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5	This transaction was executed in multiple trades at prices ranging from $166.53 to $166.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.